Table 1.
All Patients, N = 70 | |
---|---|
Age, y | 58 ± 15 |
Gender, male/female | 56/14 |
Hypertension (%) | 30 (43) |
Diabetes mellitus (%) | 13 (19) |
Smoking (%) | 28 (40) |
Prior stroke (%) | 2 (3) |
History of atrial fibrillation (%) | 12 (17) |
Ischemic origin (%) | 32 (46) |
NYHA functional class, II/III | 54/16 |
Aspirin (%) | 34 (49) |
Nitrates (%) | 15 (21) |
Calcium channel blockers (%) | 11 (16) |
β‐Blockers (%) | 35 (50) |
ACEI/ARB (%) | 53 (76) |
Diuretics (%) | 48 (69) |
Digitalis (%) | 27 (39) |
Antiarrythmic agents (%) | 16 (23) |
Abbreviations: ACEI/ARB, angiotension‐converting enzyme inhibitor/angiotension II receptor blocker; NYHA, New York Heart Association.